Cochrane · systematic review · CD010726

Nitrates for the prevention of cardiac morbidity and mortality in patients undergoing non‐cardiac surgery

Zhao, N, Xu, J, Singh, B, et al. · Cochrane Database of Systematic Reviews · 2016 · Cochrane Library

AnaesthesiaAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
12
current version
GRADE rated
9
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 3 · 25%Very low 9 · 75%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Nitroglycerin versus no treatment for prevention of cardiac morbidity and mortality in participants undergoing non‐cardiac surgery (nitroglycerin vs no treatment)

Population: patients (15 years of age and older) undergoing non‐cardiac surgery under any type of anaesthesia
6 questions
OutcomeEffectEvidenceStatus / GRADE
All‐cause mortality in 30 days post operation
Nitroglycerin vs no treatment
RR 0.33 [0.01, 7.87]1 study · 60 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Acute myocardial infarction
Nitroglycerin vs no treatment
RR 0.25 [0.03, 2.2]2 studies · 105 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Angina pectoris
Nitroglycerin vs no treatment
RR 0.43 [0.12, 1.57]2 studies · 105 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Cardiac ischaemia indicated by ECG
Nitroglycerin vs no treatment
RR 0.73 [0.42, 1.26]4 studies · 197 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Side effect (hypotension)
Nitroglycerin vs no treatment
no estimate extracted0 studies · 0 participantsUngraded
Side effect (headache)
Nitroglycerin vs no treatment
RR 3.67 [0.14, 96.14]2 studies · 6629 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency

Nitroglycerin versus placebo for prevention of cardiac morbidity and mortality in patients undergoing non‐cardiac surgery (nitroglycerin vs placebo)

Population: patients (15 years of age and older) undergoing non‐cardiac surgery under any type of anaesthesia
6 questions
OutcomeEffectEvidenceStatus / GRADE
All‐cause mortality in 30 days post operation
Nitroglycerin vs placebo
RR 2.81 [0.12, 63.83]2 studies · 89 participantsVery low
Downgraded: risk of bias, imprecision
Acute myocardial infarction
Nitroglycerin vs placebo
RR 4.69 [0.24, 89.88]1 study · 29 participantsVery low
Downgraded: risk of bias, imprecision
Angina pectoris
Nitroglycerin vs placebo
no estimate extracted0 studies · 0 participantsUngraded
Cardiac ischaemia indicated by ECG
Nitroglycerin vs placebo
no estimate extracted2 studies · 56 participantsUngraded
Side effect (hypotension)
Nitroglycerin vs placebo
RR 1.46 [0.56, 3.83]6 studies · 296 participantsVery low
Downgraded: risk of bias, imprecision
Side effect (headache)
Nitroglycerin vs placebo
RR 1.55 [0.75, 3.2]10 studies · 607 participantsVery low
Downgraded: risk of bias, imprecision